Skip to main content

JANE STREET GROUP, LLC

Position in ERAS — Erasca, Inc.

CIK 1595888 NEW YORK, NY

Position in ERAS

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$7,362,206
+$3,967,638 QoQ
Shares Held
455,019
-50.1% QoQ
Ownership
0.146%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
16 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ERAS Over Time

Shares Held

Position Value (USD)

Derivatives in ERAS

reported options exposure · as of Mar 31, 2026
CallValue
$1,467,526
CallShares
90,700
PutValue
$1,163,342
PutShares
71,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,253,826,569 across 316 Biotechnology names. ERAS ranks #33 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ERAS

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $7,362,206 455,019
2026-03-31 $1,163,342 71,900
2026-03-31 $1,467,526 90,700
2025-12-31 $3,394,568 912,519
2025-12-31 $81,840 22,000
2025-12-31 $150,660 40,500
2025-09-30 $841,629 386,069
2025-06-30 $167,980 132,269
2024-12-31 $54,376 21,664
2024-09-30 $189,904 69,562
2024-06-30 $397,451 168,412
2024-03-31 $237,397 115,242
2023-12-31 $567,546 266,454
2023-09-30 $107,294 54,464
2023-06-30 $42,087 15,249
2023-03-31 $844,497 280,564
2022-12-31 $50,892 11,808
2022-09-30 $105,744 13,557
2022-06-30 $64,606 11,599
2022-03-31 $160,458 18,658